Dublin, Feb. 27, 2024 (GLOBE NEWSWIRE) -- The "Automation in Biopharma Industry Market - Global Industry Size, Share, Trends, Opportunity, & Forecast 2018-2028" report has been added to ResearchAndMarkets.com's offering.
In a new comprehensive research study, insights into the Automation in Biopharma Industry Market reveal an upward trajectory from USD 1775.20 million in 2022 to an anticipated USD 2468.19 million by 2028.
The sector spots a projected Compound Annual Growth Rate (CAGR) of 5.80% over the six-year period. The augmentation of the market is fueled by advancements in automation technologies and an increasing demand for high-throughput screening, alongside the rising complexity of biopharmaceuticals.
Market dynamics highlight significant growth drivers, such as the integration of advanced robotics, lab-on-a-chip technologies, and the employment of artificial intelligence and machine learning. Evolving biopharma products' complexity necessitates advanced automation to ensure consistent high-quality output, bolstering the market's robust expansion.
Technological Advancements and Process Analytical Technology Shape the Biopharmaceutical Landscape
- Advancements in digitization and automation technology promote the seamless conduct of biopharmaceutical processes.
- Robotics and artificial intelligence streamline operations, enhancing drug discovery and development efficiencies.
- Process Analytical Technology (PAT) ensures real-time control and monitoring, fortifying quality assurance in biopharma manufacturing.
Complex Biopharmaceuticals Surge Demand for Precision Automation
- As therapies become more intricate, the necessity for precise automation escalates, maintaining product quality and regulatory compliance.
- The move towards personalized medicines heightens the need for bespoke automation solutions to cater to individualized treatments.
High-Throughput Screening Accelerates Drug Discovery
The surge in High-Throughput Screening (HTS) utilization emphasizes the market's direction, vital for the rapid identification of potential therapeutics and streamlining the early phases of drug development.
Market Segmentation: Broad Applications and Components Insights Applications in Production Phase Dominate Market Share
Application insights underscore the importance of the Production Phase segment, proving essential in large-scale biopharmaceutical manufacturing and maintaining a consistent quality of life-saving drugs.
Automation Software Component Emerges as Key Market Contributor
Within components, Automation Software is identified as crucial, driving operational efficiencies and fostering integrative and controlled system functionalities.
Regional Outlook Highlights North America as Market Leader
North America leads the charge in the global market, with vast investments, robust technological infrastructure, and a nurturing environment for automation within the biopharma industry.
The report provides an in-depth analysis of the important market trends, challenges, and driving forces shaping the Automation in Biopharma Industry Market. Although the market is confronted with challenges like the high cost of implementation and sustaining quality assurance, the future appears promising due to ongoing innovation and industry-led initiatives.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 175 |
| Forecast Period | 2022 - 2028 |
| Estimated Market Value (USD) in 2022 | $1775.2 Million |
| Forecasted Market Value (USD) by 2028 | $2468.19 Million |
| Compound Annual Growth Rate | 5.8% |
| Regions Covered | Global |
A selection of companies mentioned in this report includes
- PerkinElmer, Inc.
- AMETEK, Inc.
- Autodesk, Inc.
- Baumueller-Nuermont Corp
- Emerson Electric Co.
- Kawasaki Robotics
- RheoSense Inc.
- Rockwell Automation, Inc.
- Sartorius Stedim Biotech SA
- Siemens Healthineers
For more information about this report visit https://www.researchandmarkets.com/r/nlbdud
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
